CAPR vs XOM · $1.62B cap vs P/E 24, rev $201.16B
Capricor Therapeutics Inc (CAPR) versus Exxon Mobil Corp (XOM) — a side-by-side from cached financials, not a winner call.
Capricor Therapeutics Inc (CAPR) is a biotechnology company listed on NASDAQ.
Exxon Mobil Corp (XOM) is a oil & gas integrated company listed on NYSE. It is led by Darren Woods.
Latest reported CAPR revenue for 2025-12-31 was $0. Net income was -$105.0M. CAPR currently screens at market cap $1.62B.
Latest reported XOM revenue for 2026-06-30 was $201.16B. Net income was $18.71B. XOM currently screens at market cap $583.36B and trailing P/E 23.7.
CAPR currently screens at market cap $1.62B. XOM currently screens at market cap $583.36B and trailing P/E 23.7.
Not investment advice. Open the CAPR and XOM stock pages for the full models.
Not investment advice.